A Study of the Safety and Effectiveness of Levofloxacin Compared With Imipenem/Cilastatin in Patients With Pneumonia Acquired During Hospitalization
Clinical trial NCT00236834 · COMPLETED
Trial details
- NCT number
- NCT00236834
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-12-01
- Enrollment
- 438
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.